久久久国产一区二区_欧美在线小视频_高清一区二区三区_久久综合久久久_成人久久久久久久久_亚洲精品视

,Echo Therapeutics,  
成立于1989年，總部設于美國費城，主要研發(fā)非侵入性無線透皮式動態(tài)血糖監(jiān)測系統(tǒng)(CGM)，包括無針型Symphony  CGM System以及用于透皮給藥的Prelude SkinPrep System。CGM是一種會發(fā)出微小電脈到皮膚，用感應器檢測出血糖通過毛細血管的擴散，使血糖讀數(shù)發(fā)送到無線手持儀器之產(chǎn)品。產(chǎn)品主要應用于醫(yī)院中糖尿病人之臨床的設置。

Echo Therapeutics is developing the Symphony CGM System as a non-invasive, wireless, continuous glucose monitoring system. Our target is patients who could benefit from glucose monitoring in the hospital setting, including critical care. Significant opportunity also exists for patients with diabetes to use Symphony in the outpatient setting. Echo is also developing its needle-free skin preparation component of Symphony, the Prelude? SkinPrep System, as a platform technology to enhance drug delivery of topical pharmaceuticals.